Close

Have A Question?


Connect with Camargo today.

Contact Us

Media & Events

View our media coverage, awards, recognition and events related to industry-leading pharmaceutical development and commercialization work, including 505(b)(2).


Latest Media

Camargo Pharmaceutical Services Enhances Drug Development Services Through Acquisition of Montreal-based InSymbiosis

Publication: Camargo Pharmaceutical Services, via PR Newswire

Date: June 13th, 2019

Read Article

Camargo Pharmaceutical Services' Co-founder and Chief Scientific Officer Honored with "Icons of Pharmacy Award"

Publication: Camargo Pharmaceutical Services, via PR Newswire

Date: May 3rd, 2019

Read Article

Events

October 16 - 18, 2019
Philadelphia, PA

November 5 - 7, 2019
Frankfurt, Germany

November 11 - 13, 2019
Hamburg, Germany

November 21 - 21, 2019
Brussels, Belgium


2019 Media

Camargo Pharmaceutical Services to Expand Capabilities and Enhance Global Presence

Publication: Camargo Pharmaceutical Services, via PR Newswire

Date: February 26th, 2019

Read Article

2018 Media

Cellix Biosciences Announces Regulatory Pathway Confirmation for CLX-106 in the U.S.

Publication: Cellix Biosciences, via Business Wire

Date: July 11th, 2018

Read Article

Camargo Celebrates Fifteen Years

Publication: Camargo Pharmaceutical Services, via PR Newswire

Date: June 1st, 2018

Read Article

Aequus Receives Positive FDA Regulatory Guidance for Anti-Nausea Patch

Publication: Aequus Pharmaceuticals, via Globe Newswire

Date: May 3rd, 2018

Read Article

Daniel S. Duffy Appointed New CEO of Camargo Pharmaceutical Services, LLC

Publication: Camargo Pharmaceutical Services, via PR Newswire

Date: April 30th, 2018

Read Article

V ClinBio Partners with Camargo for Strategic 505(b)(2) Development of Transformative Prodrug Technology Platform

Publication: Camargo Pharmaceutical Services, via PR Newswire

Date: March 6th, 2018

Read Article

Aequus and Camargo Prepare for Meeting with FDA to Advance Anti-Nausea Patch

Publication: Aequus Pharmaceuticals, via Globe Newswire

Date: January 31st, 2018

Read Article

2017 Media

Veru Acquires Novel Proprietary Formulation for Overactive Bladder

Publication: Veru Inc., via Globe Newswire

Date: December 13th, 2017

Read Article

Camargo CEO Meeting with Leading Companies in Japan, Korea, Taiwan, and India

Publication: Camargo Pharmaceutical Services, via PR Newswire

Date: December 4th, 2017

Read Article

Veru Announces Tamsulosin DRS Bioequivalence Clinical Trial Results

Publication: Veru Inc., via Globe Newswire

Date: November 13th, 2017

Read Article

Callitas Announces Positive FDA Response to Extrinsa Pre-IND Submission

Publication: Callitas Health Inc., via AccessWire

Date: October 11th, 2017

Read Article

Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole

Publication: Aequus Pharmaceuticals, Markets Insider

Date: August 24th, 2017

Read Article

Global Health Solutions Partners with Camargo Pharmaceutical Services for Onychomycosis Development Program

Publication: Global Health Solutions, via PR Newswire

Date: August 21st, 2017

Read Article

Cingulate Therapeutics Partners with Camargo Pharmaceutical Services for Development Programs

Publication: Cingulate Therapeutics, via PR Newswire

Date: August 8th, 2017

Read Article

Quivive Pharma Partners with Camargo Pharmaceutical Services for Development Programs

Publication: Camargo Pharmaceutical Services, via PR Newswire

Date: May 4th, 2017

Read Article

Camargo Pharmaceutical Services Partners with Private Investment Firm

Publication: Camargo Pharmaceutical Services, via PR Newswire

Date: March 16th, 2017

Read Article

Impel NeuroPharma Partners with Camargo Pharmaceutical Services for Development Programs

Publication: Camargo Pharmaceutical Services, via PR Newswire

Date: February 17th, 2017

Read Article

Cocoon Biotech Announces Partnership with Camargo Pharmaceutical Services for Development Programs

Publication: Cocoon Biotech; Camargo Pharmaceutical Services, via PR Newswire

Date: February 2nd, 2017

Read Article

2016 Media

How Many FDA Premarket Applications are Necessary for Your Combination Product?

Publication: Pharmaceutical Online, Med Device Online, and Bio Process Online

Date: October 25th, 2016

Read Article

Aequus Partners with Camargo to Support US Regulatory Strategy for Development Programs

Publication: Aequus Pharmaceuticals Inc., via Market Wired

Date: October 3rd, 2016

Read Article

Camargo Pharmaceutical Services Adds to Medical Device Expertise

Publication: Camargo Pharmaceutical Services, via Newswire

Date: September 27th, 2016

Read Article

Camargo Pharmaceutical Services Grows, Adds Three Drug Development Experts

Publication: Camargo Pharmaceutical Services, via Newswire

Date: August 10th, 2016

Read Article

India’s Drugmakers Step Up US Involvement

Publication: The Wall Street Journal, article by Suryatapa Bhattacharya

Date: February 24th, 2016

Read Article

A Primer on the 505(b)(2) Pathway for Combination Drug/Device Products

Publication: Pharmaceutical Online

Date: February 16th, 2016

Read Article

Camargo Pharmaceutical Services Integral in Medicines360’s Intrauterine Contraceptive Device FDA Approval

Publication: Camargo Pharmaceutical Services, via Newswire

Date: January 19th, 2016

Read Article

2015 Media

2014 Media

Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Eli-201

Publication: Elite Pharmaceuticals, via MarketWatch

Date: July 15th, 2014

Read Article

The Right Path

Publication: European Pharmaceutical Contractor

Date: July 3rd, 2014

Download Article

Elite Pharmaceuticals Begins Human Abuse Liability Studies for Eli-200

Publication: Elite Pharmaceuticals, via MarketWatch

Date: June 9th, 2014

Read Article

Foreign Trips Sell Cincinnati to Overseas Businesses

Publication: Cincinnati Enquirer

Date: May 19th, 2014

Read Article

Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Second Opioid Abuse Deterrent Product

Publication: Elite Pharmaceuticals, via Globe Newswire

Date: January 14th, 2014

Read Article

2013 Media

2012 Media

2011 Media

2010 Media

2009 Media

2008 Media

2007 Media


Camargo Pharmaceutical Services provides comprehensive drug development solutions, specializing in customized programs including the 505(b)(2) pathway.


Contact
Headquarters
9825 Kenwood Road
Suite 203
Cincinnati OH, 45242
Durham Office
800 Taylor Street
Suite 101, Mill No. 1
Durham NC, 27701
Montreal Office
507 Place d'Armes
Suite 1101
Montreal, QC H2Y 2W8, Canada
Phone 513.561.3329
Toll Free 888.451.5708
Subscribe for our Latest Insights